Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM)…
Search Posts
News Release
701k Jobs Lost in March 2020: Statement by Iain Murray
In response to today's abysmal jobs report tallied by the federal government – 701,000 jobs lost in March as a result of the COVID-19 lockdowns.
Inside Sources
CDC Priorities Left Government Unprepared for COVID-19
It was always a matter of when — not if — a new viral pandemic would make it to America.
Blog
The Guardian Props Up Lame Greenpeace Tirade, Ignores Potential COVID-19 Risks from Reusable Grocery Bags
The Guardian recently published a story on a Greenpeace attack on CEI for pointing out that reusable grocery bags might contain dangerous pathogens, including COVID-19.
Blog
Post-Corona Politics: Opportunities and Threats
There is a lot of attention being paid to the latest emergency legislation being proposed to address the coronavirus pandemic, from $1,000 checks for every…
Blog
Getting Rid of #NeverNeeded Regulations Hindering Coronavirus Response
What can Washington do to minimize harm from the coronavirus? Some of the best policy responses are coming not from imposing new regulations, but from…
Blog
Liberty in the Time of Coronavirus Part 2
Much of the money dedicated to medical research and services comes from the federal government. While some may see this is a good way to…